Description
ZalcitABIne,alsoknownas2’,3’-dideoxycytidine,isanantiviralpyrimidinenucleosideanalogthatisclinicallyusedtotreatHIVinfection.ZalcitabineinhibitsreversetranscriptaseandpreventschainelongationwhenincorporatedintoviralDNA.
ZalcitABIne,alsoknownas2’,3’-dideoxycytidine,isanantiviralpyrimidinenucleosideanalogthatisclinicallyusedtotreatHIVinfection.ZalcitabineinhibitsreversetranscriptaseandpreventschainelongationwhenincorporatedintoviralDNA.
CasNo. | 7481-89-2 |
---|---|
Purity | ≥98% |
Formula | C9H13N3O3 |
FormulaWt. | 211.22 |
IUPACName | 4-amino-1-[(2R,5S)-5-(hydroxymethyl)oxolan-2-yl]pyrimidin-2-one |
Synonym | Zalcitabine;ddCyd;Hivid |
MeltingPoint | 215-217°C |
Solubility | Moderatelysolubleinwater. |
Appearance | WhitecrystalPowder |
StoreTemp | Ambient |
---|---|
ShipTemp | Ambient |
MSDS | D3212MSDSPDF |
---|---|
InfoSheet | D3212InfoSheetPDF |
Brochures | AntiviralsBooklet |
SheltonMJ,O"DonnellAM,MorseGD.Zalcitabine.AnnPharmacother.1993Apr;27(4):480-9.PMID:8097417.
BalzariniJ.Anti-retroviralactivityandmolecular-biochemicalactionmechanismof2",3"-dideoxynucleosideanalogsand9-(2-phosphonylmethoxyethyl)purinederivatives.VerhKAcadGeneeskdBelg.1991;53(1):61-98.PMID:1647085.